IDXX: IDEXX Laboratories, Inc. Stock

by  •  • Comments Off on IDXX: IDEXX Laboratories, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 34,690.44
Enterprise Value ($M) 35,255.70
Book Value ($M) 1,618.05
Book Value / Share 19.76
Price / Book 21.44
NCAV ($M) -298.97
NCAV / Share -3.65
Price / NCAV -116.03

Profitability (mra)
Return on Invested Capital (ROIC) 0.33
Return on Assets (ROA) 0.28
Return on Equity (ROE) 0.67

Liquidity (mrq)
Quick Ratio 1.03
Current Ratio 1.42

Balance Sheet (mrq) ($M)
Current Assets 1,433.74
Assets 3,350.77
Liabilities 1,732.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
5 days ago 13G/A Vanguard Group Inc 11.78 0.00
01-24 13G/A BlackRock, Inc. 10.90 6.48

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 127,895 582,792 21.95
2024-11-14 129,540 450,000 28.79
2024-11-13 89,574 539,109 16.62
2024-11-12 130,773 554,308 23.59
2024-11-11 128,536 538,821 23.86

(click for more detail)

Similar Companies
HOWL – Werewolf Therapeutics, Inc. HUMA – Humacyte, Inc.
IBRX – ImmunityBio, Inc. IDYA – IDEAYA Biosciences, Inc.
IFRX – InflaRx N.V.


Financial data and stock pages provided by
Fintel.io